VoxCell BioInnovation

VoxCell BioInnovation

Private
Victoria, British ColumbiaHealthcare & Life Scienceshttps://voxcell.com

Last Round

Grant

Sep 26, 2023

Total Funding Raised

$2.14M

Momentum Score

25 /100

Company Overview

VoxCell BioInnovation is a biotechnology company that develops 3D bioprinted, vascularized human-like tissue models to enhance drug development and testing accuracy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, 3D Printing, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bioprinting3D tissue modelsvascularized tissuedrug discoverybio-inkspreclinical testing3D bioprinterorgan-on-a-chipcancer tissue modelsorganoidstumoroidsanimal testing alternativein-vitro modelstissue engineeringdrug screening servicecontract research organizationCRObiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VoxCell BioInnovation Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VoxCell BioInnovation Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 26, 2023
SeedDec 7, 2022
Pre SeedAug 11, 2022
GrantJun 22, 2022
SeedJul 2, 2021

VoxCell BioInnovation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    CEO received an Emerging Alumni Award from the University of Victoria.

  • Jan 18, 2026

    Graham Craig appointed as the new CCO.

VoxCell BioInnovation Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VoxCell BioInnovation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VoxCell BioInnovation's valuation, stock price, and market status.

Firmographic Details

HeadquartersVictoria, British Columbia
Employee Range27
Year Founded2020
Last FundingSep 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.